OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Release Date
2023
(2)
2021
(2)
2022
(1)
2020
(1)
2018
(1)
2016
(1)
2015
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture.
Not available
S-EPMC5037737
|
biostudies-literature
Cite
Succinate Accumulation Is Associated with a Shift of Mitochondrial Respiratory Control and HIF-1α Upregulation in PTEN Negative Prostate Cancer Cells.
Not available
S-EPMC6073160
|
biostudies-literature
Cite
Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma-A case report.
Not available
S-EPMC7383619
|
biostudies-literature
Cite
Akacid medical formulation induces apoptosis in myeloid and lymphatic leukemic cell lines in vitro and in vivo.
Not available
S-EPMC4334520
|
biostudies-literature
Cite
Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration.
Not available
S-EPMC8985159
|
biostudies-literature
Cite
Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury.
Not available
S-EPMC8357738
|
biostudies-literature
Cite
Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation.
Not available
S-EPMC10641818
|
biostudies-literature
Cite
Factors influencing kidney transplantation rates: a study from the ERA Registry.
Not available
S-EPMC10229263
|
biostudies-literature
Cite
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial.
Not available
S-EPMC8195495
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets